Saturn V Capital Management LP

AUSTIN, TX · CIK 1964437 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2023 · limited partnership

Assets managed$793.2m
Staff6 · 4 in investment roles
Main clients (by assets)Private funds 100%
Private funds3 (3 hedge) · $793.2m gross assets
Form ADV · 2026-08-04SEC adviser record

Legal entitySaturn V Capital Management LP (US)

$697.5m reported value +26.3% vs Q1 2026

23positions

75.6%in top 10

3 new 13 added 6 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	AMYLYX PHARMACEUTICALS INC COM AMLX	AMLX	4,624,101	$83.0m11.91%	11.91%	Added +274.2k	+274,216 6.3%
2	ALUMIS INC COM ALMS	ALMS	2,915,443	$82.0m11.76%	11.76%	Reduced -286.6k	-286,632 -8.9%
3	ABIVAX SA SPONSORED ADS ABVX	ABVX	518,865	$69.1m9.91%	9.91%	Reduced -23.8k	-23,831 -4.4%
4	VAXCYTE INC COM PCVX	PCVX	852,914	$49.6m7.11%	7.11%	Added +28.4k	+28,382 3.4%
5	IMMIX BIOPHARMA INC COM IMMX	IMMX	4,658,429	$48.0m6.89%	6.89%	Added +964.8k	+964,844 26.1%
6	PHARVARIS N V COM PHVS	PHVS	1,314,122	$45.4m6.52%	6.52%	Added +112.7k	+112,720 9.4%
7	JAZZ PHARMACEUTICALS PLC SHS USD JAZZ	JAZZ	160,938	$38.8m5.56%	5.56%	Reduced -2.0k	-2,023 -1.2%
8	CELCUITY INC COM CELC	CELC	370,318	$38.7m5.55%	5.55%	Added +88.4k	+88,414 31.4%
9	DISC MEDICINE INC COM IRON	IRON	524,730	$38.4m5.50%	5.50%	Added +74.8k	+74,804 16.6%
10	CANDEL THERAPEUTICS INC COM CADL	CADL	3,303,686	$34.0m4.88%	4.88%	Added +407.1k	+407,098 14.1%
11	X4 PHARMACEUTICALS INC COM NEW XFOR	XFOR	6,973,343	$32.6m4.67%	4.67%	Added +516.7k	+516,697 8.0%
12	MONOPAR THERAPEUTICS INC COM NEW MNPR	MNPR	311,976	$28.9m4.14%	4.14%	Reduced -33.6k	-33,650 -9.7%
13	DYNE THERAPEUTICS INC COM DYN	DYN	1,057,493	$23.5m3.37%	3.37%	Added +90.9k	+90,884 9.4%
14	TREVI THERAPEUTICS INC COM TRVI	TRVI	1,052,043	$19.6m2.81%	2.81%	New
15	ZURA BIO LTD CLASS A ORD SHS ZURA	ZURA	2,101,119	$12.4m1.78%	1.78%	Added +1.4m	+1,361,159 183.9%
16	SAGIMET BIOSCIENCES INC COM SER A SGMT	SGMT	1,479,918	$11.4m1.64%	1.64%	New
17	OCULIS HOLDING AG ORDINARY SHARES OCS	OCS	684,880	$9.5m1.36%	1.36%	Added +168.1k	+168,119 32.5%
18	INHIBIKASE THERAPEUTICS INC COM NEW IKT	IKT	3,869,056	$7.9m1.13%	1.13%	Added +5.6k	+5,611 0.1%
19	VIR BIOTECHNOLOGY INC COM VIR	VIR	770,643	$7.9m1.13%	1.13%	New
20	INVIVYD INC COM IVVD	IVVD	8,392,288	$7.3m1.05%	1.05%	Reduced -2.6m	-2,556,796 -23.4%
21	ALTO NEUROSCIENCE INC COM SHS ANRO	ANRO	182,829	$4.8m0.69%	0.69%	Added +93.8k	+93,830 105.4%
22	SATELLOS BIOSCIENCE INC COM MSLE	MSLE	350,000	$2.7m0.39%	0.39%	Unchanged
23	OVID THERAPEUTICS INC COM OVID	OVID	663,060	$1.8m0.26%	0.26%	Reduced -3.5m	-3,503,606 -84.1%

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
COGENT BIOSCIENCES INC COGT	COGT	626,635	$24.1m626.6k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-02-17	XFOR	7.4%≈ $30.0m	new	13G	2026-02-17
IMMIX BIOPHARMA INC IMMX · 13G · filed 2026-02-17	IMMX	7.0%≈ $38.1m	new	13G	2026-02-17